Please contact us to schedule a meeting with our team to discuss potential cooperation and your clinic’s needs. Together, we can expand access to high-quality fertility care for patients worldwide.
Ovumia Group operates in full compliance with both European and national regulations governing assisted reproductive technologies. Our clinical and laboratory processes follow strict regulatory frameworks across multiple jurisdictions, ensuring the highest standards of safety, quality, and ethical responsibility.
Ovumia Group operates under strict quality management systems to maintain consistency, safety, and clinical excellence.
Our clinical and laboratory procedures comply with the requirements of the SoHO Regulation EU 2024/1938 and the EU Tissues and Cells Directive, which establishes standards for the donation, procurement, testing, processing, preservation, storage, and distribution of human tissues and cells within Europe.
In addition to regulatory compliance, Ovumia laboratories operate under internationally recognized quality management systems and adhere to ISO 9001 principles for quality assurance and operational excellence.
This commitment to European regulations and internationally recognized quality standards ensures that Ovumia maintains a high level of safety, transparency, and reliability in all fertility treatments and donor programs.
Ovumia Group is a leading Nordic fertility care provider with clinics and operations across Finland, Estonia, Sweden, and Ukraine. We collaborate with fertility clinics worldwide by providing high-quality donor programs, vitrified donor oocytes, and clinical expertise.Through these collaborations, we ensure that patients receive high-quality, personalized treatments closer to home while benefiting from our expertise in egg donation, sperm donation, and blastocyst creation for B2B partner clinics.
Ovumia is an independent part of the FutureLife group, which is the largest provider of assisted reproduction services in Europe operating in 16 countries. This chain of IVF clinics performs more than 77,000 fertility treatments annually. Our B2B collaborations allow partner clinics to benefit from Ovumia Group’s expertise and infrastructure.
Donor oocyte supply: Ovumia offers access to carefully screened egg donors and high-quality vitrified donor oocytes.
Ovumia provides high-quality blastocysts created with carefully screened donor oocytes and husband or donor sperm. Using advanced laboratory technologies with continuous monitoring of embryo development our highly skilled embryologists select the best blastocysts for recipient treatment.
Our blastocyst creation process includes:
We recognize that every B2B customer clinic operates within a unique regulatory and clinical environment. For this reason, Ovumia offers flexible partnership structures with a high regulatory competence, including:
Our partnership team works closely with each clinic to create a collaboration model aligned with their operational needs.
One of our team members will be in touch shortly through your preferred method of communication.
Please contact us to schedule a meeting with our team to discuss potential cooperation and your clinic’s needs. Together, we can expand access to high-quality fertility care for patients worldwide.